Annamaria Brioli

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Leukemia

Journal of cancer research and clinical oncology

Annals of hematology

Cancers

Universitätsklinikum Jena

Università degli Studi di Bologna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitätsklinikum Jena

Germany

Specialist in Haematology, Postdoc :: Klinik für Innere Medizin II, Abt. Hämatologie und internistische Onkologie

Università degli Studi di Bologna Istituto di Ematologia Lorenzo e Ariosto Seràgnoli

Italy

Registrar, PhD :: Haematology

Royal Marsden Hospital Sutton

United Kingdom

Research Registrar :: Haematology

Institute of Cancer Research

United Kingdom

PhD, visiting research fellow :: Division of Molecular Pathology

Education History

Università degli Studi di Bologna

Italy

PHD

Università degli Studi di Bologna Scuola di Medicina e Chirurgia

Italy

PHD

Publications

Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Annamaria Brioli, Laura Gengenbach, Katia Mancuso, Mascha Binder, Thomas Ernst, Florian H Heidel, Thomas Stauch, Elena Zamagni, Inken Hilgendorf, Andreas Hochhaus, Monika Engelhardt, Marie von Lilienfeld-Toal
Pomalidomide combinations are a safe and effective option after daratumumab failure. Journal of cancer research and clinical oncology (2023)
Sven Stengel, Kevin R Petrie, Yordan Sbirkov, Clara Stanko, Faezeh Ghazvini Zadegan, Veronica Gil, Rafał Skopek, Paweł Kamiński, Lukasz Szymanski, Annamaria Brioli, Arthur Zelent, Tino Schenk
Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia. British journal of haematology 198 (2) (2022)
Jacqueline Schütt, Theresa Nägler, Tino Schenk, Annamaria Brioli
Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications. Cancers 13 (16) (2021)
Annamaria Brioli, Felix Vom Hofe, Paola Rucci, Thomas Ernst, Olaposi Yomade, Inken Hilgendorf, Sebastian Scholl, Herbert Sayer, Lars-Olof Mügge, Andreas Hochhaus, Marie von Lilienfeld-Toal
Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients. Bone marrow transplantation 56 (5) (2020)
Carl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, Dietrich Kämpfe, Martin Griesshammer, Konstanze Döhner, Philipp J Jost, Denise Wolleschak, Susanne Isfort, Frank Stegelmann, Stefanie Jilg, Verena Hofmann, Guiseppe Auteri, Tobias Rachow, Philipp Ernst, Annamaria Brioli, Marie von Lilienfeld-Toal, Andreas Hochhaus, Francesca Palandri, Florian H Heidel
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study. Leukemia 34 (7) (2020)
Annamaria Brioli, Kirsi Manz, Markus Pfirrmann, Mathias Hänel, Andreas Christoph Schwarzer, Gabriele Prange-Krex, Christian Fabisch, Stefan Knop, Thomas Illmer, Beate Krammer-Steiner, Andreas Hochhaus, Marie von Lilienfeld-Toal, Lars-Olof Mügge
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN). Journal of cancer research and clinical oncology 146 (3) (2019)
Annamaria Brioli, Maximilian Klaus, Herbert Sayer, Sebastian Scholl, Thomas Ernst, Inken Hilgendorf, André Scherag, Olaposi Yomade, Kristina Schilling, Andreas Hochhaus, Lars-Olof Mügge, Marie von Lilienfeld-Toal
The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey. Annals of hematology 98 (3) (2019)

Annamaria Brioli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Annamaria Brioli